• Rotavirus-Induced Downregulation of Nrf2: Mechanisms and Imp

  2026-05-15

  This study delineates how progressive rotavirus infection actively suppresses the redox-sensitive transcription factor Nrf2 and its downstream cytoprotective genes, highlighting a viral strategy to undermine host antioxidant defenses. The findings provide a mechanistic foundation for exploring Nrf2-modulating interventions in viral pathogenesis and cellular stress research.

• Fluorescein TSA Fluorescence System Kit: Amplifying Sensitiv

  2026-05-15

  The Fluorescein TSA Fluorescence System Kit delivers unrivaled sensitivity for detecting low-abundance targets in fixed cells and tissues via robust tyramide signal amplification. This article unpacks experimental workflows, real-world troubleshooting, and key innovations—translating reference study insights into actionable protocol enhancements for modern immunohistochemistry, immunocytochemistry, and in situ hybridization.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Workflow Gu

  2026-05-14

  The PKH26 Red Fluorescent Cell Linker Kit enables stable, minimally toxic fluorescent labeling of cell membrane lipid regions for cell tracing and proliferation detection in vitro and in vivo. It should not be used for intracellular or non-membrane labeling applications. This kit is best suited for studies requiring long-term membrane fluorescence and reliable tracking of cell division.

• TNF-alpha Recombinant Murine Protein: Applied Cell Death Res

  2026-05-14

  Harness TNF-alpha recombinant murine protein for precise apoptosis and inflammation modeling—now with new insights from transcription-independent cell death pathways. This guide details stepwise protocols, optimization strategies, and cutting-edge applications, leveraging both classic and emerging mechanistic frameworks.

• Epalrestat in Cancer Fructose Metabolism: Next-Gen Polyol Pa

  2026-05-13

  Explore how Epalrestat, a leading aldose reductase inhibitor, is transforming oxidative stress and cancer metabolism research by precisely targeting the polyol pathway. This article uniquely bridges cutting-edge findings in fructose metabolism with advanced assay considerations.

• Paroxetine Mesylate Inhibits MET/ERBB3 in Colorectal Cancer

  2026-05-13

  The referenced study demonstrates that Paroxetine Mesylate, a selective serotonin reuptake inhibitor, exhibits potent anticancer effects in human colorectal cancer cells by targeting the receptor tyrosine kinases MET and ERBB3. This work highlights the promise of drug repurposing in oncology and provides mechanistic insight into multi-targeted cancer therapy.

• Dual-Action Kinase Inhibitors Shape p38α MAPK Dephosphorylat

  2026-05-12

  This study uncovers that select kinase inhibitors not only block p38α MAPK activity but also accelerate its dephosphorylation by stabilizing a conformation preferred by phosphatases. These findings provide a mechanistic basis for designing dual-action inhibitors with improved specificity, offering new opportunities in inflammation and apoptosis research.

• Androgen Receptor and ARv7 in TNBC: Prognostic Impact and EP

  2026-05-12

  This study delineates the prognostic significance of androgen receptor (AR) and its splice variant ARv7 in triple-negative breast cancer (TNBC), demonstrating that their expression correlates with poor outcomes and increased metastasis. The research highlights that targeted inhibition using EPI-001 suppresses metastatic and epithelial–mesenchymal transition (EMT) markers in TNBC models, suggesting novel intervention strategies for AR-driven breast cancer.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Workflow Mastery

  2026-05-11

  Accelerate apoptosis detection with the One-step TUNEL Cy5 Apoptosis Detection Kit, offering unmatched sensitivity and streamlined protocols for both tissue sections and cultured cells. Explore advanced troubleshooting, protocol enhancements, and translational research strategies rooted in the latest immune-metabolic discoveries.

• Mubritinib (TAK 165): Mitochondrial Inhibition Redefined for

  2026-05-11

  Explore how Mubritinib (TAK 165) advances research in chemotherapy-resistant acute myeloid leukemia and KSHV-driven lymphoma. This in-depth analysis reveals distinct mitochondrial targeting mechanisms and practical assay guidance, setting it apart in cancer biology.

• SB 431542: Strategic Insights for Translational TGF-β Resear

  2026-05-10

  This article delivers a deep dive into the mechanistic and translational opportunities unlocked by SB 431542, a gold-standard ALK5 inhibitor. By connecting foundational TGF-β signaling biology with emerging evidence from environmental lung injury models and competitive product intelligence, we offer translational researchers actionable, evidence-based guidance for protocol optimization and next-generation workflow design. This perspective escalates the discussion beyond standard product pages by blending mechanistic nuance, protocol parameters, and strategic foresight, while contextually highlighting the capabilities of APExBIO’s SB 431542.

• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-05-09

  Wu et al. reveal that selective autophagy, mediated by CALCOCO2/NDP52 and regulated by PSMD14, controls the degradation of IRF3, a key transcription factor in type I interferon (IFN) signaling. These findings clarify how the innate immune system balances antiviral responses with immune suppression, offering mechanistic insights for immunology and cell signaling research.

• Comparative In Vitro Efficacy of Sisomicin and Tobramycin

  2026-05-09

  Stewart and Bodey's seminal study systematically evaluated the in vitro antimicrobial activity of sisomicin, a novel aminoglycoside antibiotic, against a broad panel of clinical bacterial isolates. Their findings clarified sisomicin’s potency relative to established agents like tobramycin and highlighted key resistance and susceptibility patterns, informing experimental design in antibiotic resistance research.

• Apigenin: Translational Leverage in Oncology and Neuroprotec

  2026-05-08

  This article explores Apigenin’s mechanistic breadth as a histone deacetylase inhibitor, spanning malignant mesothelioma research and emerging neuroprotective strategies for Alzheimer’s disease. We synthesize recent experimental evidence, offer strategic guidance for translational researchers, and detail assay protocol parameters to maximize research outcomes. By bridging oncological and neurological applications, we set a new paradigm for leveraging plant-derived flavonoids in preclinical pipelines.

• Targeting Pancreatic Fibrosis: UCMSC-EVs and MFGE8-ANXA1-SMA

  2026-05-07

  This study demonstrates that umbilical cord-derived mesenchymal stem cells (UCMSCs) and their extracellular vesicles (EVs) attenuate pancreatic fibrosis in chronic pancreatitis models by modulating the MFGE8-dependent ANXA1-SMAD2/3 pathway. The work introduces a nanomedicine platform (rhMFGE8 NPs) with robust antifibrotic efficacy, providing a new mechanistic foundation for developing targeted therapies for chronic pancreatitis.

16060 records 1/1071 page Next 12345 下5页 Last page